Hydrocephalus Publications Archives | CereVasc | Neurological Disease Device Company

23 Jan, 2024

Prevalence of Possible Idiopathic Normal Pressure Hydrocephalus in Sweden

cerevasc2024-02-16T22:39:04+00:00January 23rd, 2024|

08 Apr, 2021

Case 10-2021: A 70-Year-Old Man with Depressed Mood, Unsteady Gait, and Urinary Incontinence

Admin2023-12-19T22:48:26+00:00April 8th, 2021|

29 May, 2020

Readmission and reoperation for hydrocephalus: a population-based analysis across the spectrum of age

Admin2023-12-20T21:56:17+00:00May 29th, 2020|

16 Jan, 2017

Forty years of shunt surgery at Rigshospitalet, Denmark: a retrospective study comparing past and present rates and causes of revision and infection

Admin2023-12-20T21:55:31+00:00January 16th, 2017|

08 Dec, 2015

Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

cerevasc2023-12-20T22:35:03+00:00December 8th, 2015|

08 Dec, 2015

An update on research priorities in hydrocephalus: overview of the third National Institutes of Health–sponsored symposium “Opportunities for Hydrocephalus Research: Pathways to Better Outcomes”

cerevasc2023-12-20T22:20:24+00:00December 8th, 2015|

08 Oct, 2013

Diagnosis and management of idiopathic normal-pressure hydrocephalus

cerevasc2023-12-19T22:21:01+00:00October 8th, 2013|

01 Nov, 2012

Patterns in neurosurgical adverse events: cerebrospinal fluid shunt surgery

cerevasc2023-12-20T22:25:50+00:00November 1st, 2012|

01 Oct, 2011

Management of Adult Hydrocephalus With Ventriculoperitoneal Shunts: Long-Term Single-Institution Experience

cerevasc2023-12-20T22:39:13+00:00October 1st, 2011|

01 Jan, 2005

Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment

cerevasc2023-12-20T22:41:09+00:00January 1st, 2005|